The post Retail Investors in DAT More Likely to Lose Funds After $17B Market Wipeout: Bloomberg appeared on BitcoinEthereumNews.com. The losses to the retail investors in these types of DAT structures could continue to rise as billions of dollars in crypto market value keep going. According to some recent estimates, more than $17 billion in value has been wiped out. DAT Strategies Leave Retail Traders Holding the Bag A Bloomberg analysis suggests that retail traders have witnessed lesser returns on investment due to the recent market changes. Already, investor trust is being shaken in these vehicles as Bitcoin fell below $100,000. Many DATs that once traded at a premium now trade below net asset value. “These structures can function like circular trades,” Chris Holland of HM said. “if liquidity is ever truly tested, retail investors may be left holding the losses the structure was meant to avoid,” he shared. Source: Bloomberg A selloff like what happened in October sent many of those in-kind vehicles downward. According to 10X Research, retail investors have absorbed at least $17 billion in losses after investing in DAT equities modeled after Michael Saylor’s Strategy. Meanwhile, sponsors are increasingly turning to in-kind contributions. This is a system in which sponsors deposit their own tokens rather than raise fiat to buy on the open market. Usually, these tokens are unlisted or highly illiquid. This might start to shift how risk is allocated. Often, that which seems to be capital inflow is recycled. However, when the markets turn, the fallout could reach the shareholders, mainly the retail traders. Projects That Priced Out Their Public Backers One example of this is Flora Growth Corp. The company in September announced a $401 million DAT linked to Zero Gravity tokens. But only $35 million of that came in cash. The rest was made up of tokens valued at $3 each.  After listing, those tokens dropped to nearly $1.20. This undermined… The post Retail Investors in DAT More Likely to Lose Funds After $17B Market Wipeout: Bloomberg appeared on BitcoinEthereumNews.com. The losses to the retail investors in these types of DAT structures could continue to rise as billions of dollars in crypto market value keep going. According to some recent estimates, more than $17 billion in value has been wiped out. DAT Strategies Leave Retail Traders Holding the Bag A Bloomberg analysis suggests that retail traders have witnessed lesser returns on investment due to the recent market changes. Already, investor trust is being shaken in these vehicles as Bitcoin fell below $100,000. Many DATs that once traded at a premium now trade below net asset value. “These structures can function like circular trades,” Chris Holland of HM said. “if liquidity is ever truly tested, retail investors may be left holding the losses the structure was meant to avoid,” he shared. Source: Bloomberg A selloff like what happened in October sent many of those in-kind vehicles downward. According to 10X Research, retail investors have absorbed at least $17 billion in losses after investing in DAT equities modeled after Michael Saylor’s Strategy. Meanwhile, sponsors are increasingly turning to in-kind contributions. This is a system in which sponsors deposit their own tokens rather than raise fiat to buy on the open market. Usually, these tokens are unlisted or highly illiquid. This might start to shift how risk is allocated. Often, that which seems to be capital inflow is recycled. However, when the markets turn, the fallout could reach the shareholders, mainly the retail traders. Projects That Priced Out Their Public Backers One example of this is Flora Growth Corp. The company in September announced a $401 million DAT linked to Zero Gravity tokens. But only $35 million of that came in cash. The rest was made up of tokens valued at $3 each.  After listing, those tokens dropped to nearly $1.20. This undermined…

Retail Investors in DAT More Likely to Lose Funds After $17B Market Wipeout: Bloomberg

The losses to the retail investors in these types of DAT structures could continue to rise as billions of dollars in crypto market value keep going. According to some recent estimates, more than $17 billion in value has been wiped out.

DAT Strategies Leave Retail Traders Holding the Bag

A Bloomberg analysis suggests that retail traders have witnessed lesser returns on investment due to the recent market changes. Already, investor trust is being shaken in these vehicles as Bitcoin fell below $100,000.

Many DATs that once traded at a premium now trade below net asset value. “These structures can function like circular trades,” Chris Holland of HM said. “if liquidity is ever truly tested, retail investors may be left holding the losses the structure was meant to avoid,” he shared.

Source: Bloomberg

A selloff like what happened in October sent many of those in-kind vehicles downward. According to 10X Research, retail investors have absorbed at least $17 billion in losses after investing in DAT equities modeled after Michael Saylor’s Strategy.

Meanwhile, sponsors are increasingly turning to in-kind contributions. This is a system in which sponsors deposit their own tokens rather than raise fiat to buy on the open market. Usually, these tokens are unlisted or highly illiquid.

This might start to shift how risk is allocated. Often, that which seems to be capital inflow is recycled. However, when the markets turn, the fallout could reach the shareholders, mainly the retail traders.

Projects That Priced Out Their Public Backers

One example of this is Flora Growth Corp. The company in September announced a $401 million DAT linked to Zero Gravity tokens. But only $35 million of that came in cash. The rest was made up of tokens valued at $3 each. 

After listing, those tokens dropped to nearly $1.20. This undermined the deal’s equity structure. Flora Growth shares have since tanked more than 65%.

Besides this, Alt5 Sigma raised $1.5 billion to purchase World Liberty Financial tokens. Half of that was comprised of WLFI tokens priced at $0.20 before they were even publicly traded. Both companies have seen drops in their stock prices since they began their treasuries.

Also, Tharimmune raised $545 million with 80% of the funds in unlisted Canton tokens. When the token finally hit exchanges, it fell almost 50%. That dragged investor equity along with it. As one analyst put it, “an 80% in-kind DAT is effectively a thin equity wrapper around a single volatile token.”

Source: https://coingape.com/retail-investors-in-dat-more-likely-to-lose-funds-after-17b-market-wipeout-bloomberg/

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.002212
$0.002212$0.002212
-5.02%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23